ArticleResearch square2026

Model-dependent GD2 upregulation in Ewing sarcoma with the EZH2 inhibitor tazemetostat: Prerequisites for combination with GD2-specific CAR T cells.

Lara Bücker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.